Changes in type II cell populations in monocrotaline pneumotoxicity

Dennis W Wilson, H. J. Segall

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Unlike many other systemically administered pneumotoxicants affecting alveolar septa, Monocrotaline (MCT) does not cause a proliferative type II cell response. To determine whether MCT has an effect that might alter the type II cell response, we determined the numerical density and volume of type II cells in lungs from MCT-treated rats. Morphometric parameters were derived from estimates of nuclear volume based on point and intercept ratios counted in electron micrographs of type II cell profiles. These were combined with point and intercept counts of alveolar septal structures and counts of nuclear profiles per unit area to calculate average cell volume and numerical density of type II cells. Areal densities of type II cell profiles were determined by light microscopic counts of alveolar parenchyma and normalized to the volume of lung parenchyma. Cell volume of type II cells was markedly increased in MCT-treated animals (1.25 × 103 μm3) compared with controls (3.4 × 102 μm3). Nuclear diameter of type II cells was similarly increased (8.53 μm in treated animals versus 5.81 μm in controls). The number of type II cells was markedly decreased in treated animals (1.36 × 106) cells per cm3 lung parenchyma compared with 7.65 × 106 cells per cm3 parenchyma in controls). We conclude that MCT causes marked cellular hypertrophy of type II alveolar epithelial cells and that this hypertrophy is somehow related to a failure to maintain normal cell populations in the lung of MCT-treated rats. We hypothesize that this change is analogous to the hypertrophy and mitotic inhibition that occurs in the liver of animals treated with hepatotoxic pyrrolizidine alkaloids.

Original languageEnglish (US)
Pages (from-to)1293-1299
Number of pages7
JournalAmerican Journal of Pathology
Volume136
Issue number6
StatePublished - Jun 1990

Fingerprint

Monocrotaline
Population
Cell Size
Hypertrophy
Lung
Cell Count
Pyrrolizidine Alkaloids
Alveolar Epithelial Cells
Electrons
Light

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Changes in type II cell populations in monocrotaline pneumotoxicity. / Wilson, Dennis W; Segall, H. J.

In: American Journal of Pathology, Vol. 136, No. 6, 06.1990, p. 1293-1299.

Research output: Contribution to journalArticle

@article{0506f2cd528f42f5ae92ca35670df7a5,
title = "Changes in type II cell populations in monocrotaline pneumotoxicity",
abstract = "Unlike many other systemically administered pneumotoxicants affecting alveolar septa, Monocrotaline (MCT) does not cause a proliferative type II cell response. To determine whether MCT has an effect that might alter the type II cell response, we determined the numerical density and volume of type II cells in lungs from MCT-treated rats. Morphometric parameters were derived from estimates of nuclear volume based on point and intercept ratios counted in electron micrographs of type II cell profiles. These were combined with point and intercept counts of alveolar septal structures and counts of nuclear profiles per unit area to calculate average cell volume and numerical density of type II cells. Areal densities of type II cell profiles were determined by light microscopic counts of alveolar parenchyma and normalized to the volume of lung parenchyma. Cell volume of type II cells was markedly increased in MCT-treated animals (1.25 × 103 μm3) compared with controls (3.4 × 102 μm3). Nuclear diameter of type II cells was similarly increased (8.53 μm in treated animals versus 5.81 μm in controls). The number of type II cells was markedly decreased in treated animals (1.36 × 106) cells per cm3 lung parenchyma compared with 7.65 × 106 cells per cm3 parenchyma in controls). We conclude that MCT causes marked cellular hypertrophy of type II alveolar epithelial cells and that this hypertrophy is somehow related to a failure to maintain normal cell populations in the lung of MCT-treated rats. We hypothesize that this change is analogous to the hypertrophy and mitotic inhibition that occurs in the liver of animals treated with hepatotoxic pyrrolizidine alkaloids.",
author = "Wilson, {Dennis W} and Segall, {H. J.}",
year = "1990",
month = "6",
language = "English (US)",
volume = "136",
pages = "1293--1299",
journal = "American Journal of Pathology",
issn = "0002-9440",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Changes in type II cell populations in monocrotaline pneumotoxicity

AU - Wilson, Dennis W

AU - Segall, H. J.

PY - 1990/6

Y1 - 1990/6

N2 - Unlike many other systemically administered pneumotoxicants affecting alveolar septa, Monocrotaline (MCT) does not cause a proliferative type II cell response. To determine whether MCT has an effect that might alter the type II cell response, we determined the numerical density and volume of type II cells in lungs from MCT-treated rats. Morphometric parameters were derived from estimates of nuclear volume based on point and intercept ratios counted in electron micrographs of type II cell profiles. These were combined with point and intercept counts of alveolar septal structures and counts of nuclear profiles per unit area to calculate average cell volume and numerical density of type II cells. Areal densities of type II cell profiles were determined by light microscopic counts of alveolar parenchyma and normalized to the volume of lung parenchyma. Cell volume of type II cells was markedly increased in MCT-treated animals (1.25 × 103 μm3) compared with controls (3.4 × 102 μm3). Nuclear diameter of type II cells was similarly increased (8.53 μm in treated animals versus 5.81 μm in controls). The number of type II cells was markedly decreased in treated animals (1.36 × 106) cells per cm3 lung parenchyma compared with 7.65 × 106 cells per cm3 parenchyma in controls). We conclude that MCT causes marked cellular hypertrophy of type II alveolar epithelial cells and that this hypertrophy is somehow related to a failure to maintain normal cell populations in the lung of MCT-treated rats. We hypothesize that this change is analogous to the hypertrophy and mitotic inhibition that occurs in the liver of animals treated with hepatotoxic pyrrolizidine alkaloids.

AB - Unlike many other systemically administered pneumotoxicants affecting alveolar septa, Monocrotaline (MCT) does not cause a proliferative type II cell response. To determine whether MCT has an effect that might alter the type II cell response, we determined the numerical density and volume of type II cells in lungs from MCT-treated rats. Morphometric parameters were derived from estimates of nuclear volume based on point and intercept ratios counted in electron micrographs of type II cell profiles. These were combined with point and intercept counts of alveolar septal structures and counts of nuclear profiles per unit area to calculate average cell volume and numerical density of type II cells. Areal densities of type II cell profiles were determined by light microscopic counts of alveolar parenchyma and normalized to the volume of lung parenchyma. Cell volume of type II cells was markedly increased in MCT-treated animals (1.25 × 103 μm3) compared with controls (3.4 × 102 μm3). Nuclear diameter of type II cells was similarly increased (8.53 μm in treated animals versus 5.81 μm in controls). The number of type II cells was markedly decreased in treated animals (1.36 × 106) cells per cm3 lung parenchyma compared with 7.65 × 106 cells per cm3 parenchyma in controls). We conclude that MCT causes marked cellular hypertrophy of type II alveolar epithelial cells and that this hypertrophy is somehow related to a failure to maintain normal cell populations in the lung of MCT-treated rats. We hypothesize that this change is analogous to the hypertrophy and mitotic inhibition that occurs in the liver of animals treated with hepatotoxic pyrrolizidine alkaloids.

UR - http://www.scopus.com/inward/record.url?scp=0025328758&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025328758&partnerID=8YFLogxK

M3 - Article

VL - 136

SP - 1293

EP - 1299

JO - American Journal of Pathology

JF - American Journal of Pathology

SN - 0002-9440

IS - 6

ER -